FDA Adverse Event Summary report: N

CRUX VENA CAVA FILTER SYSTEM

MDR report key: 3760729 · Received April 4, 2014

Report

Report Number
2939520-2014-00025
Date Received
April 4, 2014
Date of Event
March 7, 2014
Report Date
March 7, 2014
Manufacturer
VOLCANO CORPORATION
Product Code
DTK
PMA / PMN Number
K122585
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS DEVICE WAS NOT RETURNED TO THE MFR AND THE SERIAL NUMBER OR LOT NUMBER OF THE FILTER SYSTEM WAS NOT REPORTED. THEREFORE, MFG DOCUMENTATION FOR THIS DEVICE WAS UNABLE TO BE REVIEWED TO CONFIRM THAT THE DEVICE MET ALL QUALITY AND MFG CRITERIA. A SUPPLEMENTAL REPORT WILL BE SUBMITTED WHEN THE MFG'S CLINICAL AFFAIRS DEPARTMENT COMPLETES THE EVAL REPORT OF THIS CASE.

Description of Event or Problem · 1

A (B)(6) FEMALE HAD CRUX VCF IMPLANTED SOMETIME IN (B)(6) 2013 PRIOR TO SCHEDULED PANCREATIC SURGERY. PT HAS A HISTORY OF VTE WITH CHRONIC DVT. THIS PT PRESENTED WITH LEG PAIN AND SWELLING. THE DOCTOR REPORTED, A CT SCAN WAS DONE WHICH SHOWED THROMBOSIS OF THE ILIAC VEINS AND IVC TO THE LEVEL OF THE CRUX VCF. THE PT WAS PUT ON ANTICOAGULANTS AND DEVELOPED A G1 BLEED SO IS NOW CONTRAINDICATED FOR ANTICOAGULANT TREATMENT. CT REPORT COMPLETED ON (B)(6) 2014 RECEIVED BY VOLCANO CORPORATION CUSTOMER SERVICE REP HAD NO MENTION OF ILIAC VEIN THROMBOSIS. THE PT HAD OPEN PANCREATIC SURGERY FOR CANCER AND HAD BEEN ON CHEMOTHERAPY. CURRENTLY, THE PT WAS DIAGNOSED WITH METASTATIC DISEASE. IT WAS REPORTED THAT THE PT HAD CHRONIC DVT LOWER THAN THE ILIAC VEINS AS WELL AS HYPER-COAGULAPHY. THE PT IS FEELING BETTER BUT REMAINS VERY SICK RELATED TO HER COMORBIDITIES. CURRENTLY, THERE WAS NO PLANS FOR INTERVENTION OF THE CRUX VCF THROMBOSIS AND AT THIS TIME, NO SURGICAL INTERVENTION IS NEEDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
203594 CRUX VENA CAVA FILTER SYSTEM FILTER, INTRAVASCULAR, CARDIOVASCULAR DTK VOLCANO CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 67 YR